Pediatric Bipolar Depression
Public ClinicalTrials.gov record NCT00811473. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An 8-week, Multicenter, Double-blind, Randomized, Parallel-group, Placebo-controlled Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended-Release in Children and Adolescent Subjects With Bipolar Depression
Study identification
- NCT ID
- NCT00811473
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 193 participants
Conditions and interventions
Conditions
Interventions
- Quetiapine XR Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 10 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2008
- Primary completion
- Oct 31, 2010
- Completion
- Oct 31, 2010
- Last update posted
- Jul 14, 2014
2009 – 2010
United States locations
- U.S. sites
- 31
- U.S. states
- 24
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Dothan | Alabama | — | — |
| Research Site | Scottsdale | Arizona | — | — |
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Escondido | California | — | — |
| Research Site | Bradenton | Florida | — | — |
| Research Site | Gainsville | Florida | — | — |
| Research Site | North Miami | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Smyrna | Georgia | — | — |
| Research Site | Eagle | Idaho | — | — |
| Research Site | Hoffman Estates | Illinois | — | — |
| Research Site | Terre Haute | Indiana | — | — |
| Research Site | Overland Park | Kansas | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Clinton Township | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Flowood | Mississippi | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Lincoln | Nebraska | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Cleveland | Ohio | — | — |
| Research Site | Mason | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Wharton | Texas | — | — |
| Research Site | Virginia Beach | Virginia | — | — |
| Research Site | Bothell | Washington | — | — |
| Research Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00811473, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00811473 live on ClinicalTrials.gov.